Dendreon Corp

Dendreon Corp. (DNDN) on Move

3 Reasons You Shouldn't Buy Stocks in Biotech

StockCall Pre-Market Review on ACAD, DNDN, MDVN, CTIC, and SRPT (NAS,NAS,NAS,NAS:ACAD,DNDN,MDVN,CTIC)

Dendreon investors should remain on sidelines, says RW Baird

"Dendreon Corporation (DNDN) - Financial and Strategic SWOT Analysis Review" now available at Fast Market Research

5 Names With Sharp Rises In Short Interest

Pessimists Continue to Target Dendreon Corporation (DNDN)

Pessimists Continue to Target Dendreon Corporation (DNDN)

Dendreon management to meet with Needham

Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 ASCO Annual Meeting